Endophthalmitis prophylaxis in cataract surgery

Overview of current practice patterns around the world

Andrzej Grzybowski, Stephen Schwartz, Kazuki Matsuura, Stephan O. Tone, Steve Arshinoff, Jonathon Q. Ng, Jay J. Meyer, Wu Liu, Soosan Jacob, Mark Packer, Rifna Lutfiamida, Sjakon Tahija, Paul Roux, Boris Malyugin, Julio A. Urrets-Zavalia, Nicolas Crim, Evangelina Esposito, Pablo Daponte, Fernando Pellegrino, Enrique O. Graue-Hernandez & 7 others Aida Jimenez-Corona, Jorge E. Valdez-Garcia, Julio C. Hernandez-Camarena, Nidhi Relhan, Harry W Flynn, Ravilla D. Ravindran, Anders Behnding

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Acute-onset postoperative endophthalmitis after cataract surgery remains a rare but important cause of visual loss. There is no global consensus regarding the optimal strategies for prophylaxis of endophthalmitis and practices vary substantially around the world, especially with respect to the use of intracameral antibiotics. The European Society of Cataract & Refractive Surgeons in a randomized clinical trial (2007) reported an approximately 5-fold reduction in endophthalmitis rates associated with the use of intracameral cefuroxime. Despite this report, the use of intracameral antibiotics has not been universally adopted. Methods: Various endophthalmitis prophylaxis patterns around the world (including the United States, Canada, Australia/New Zealand, Japan, China, India, Indonesia, South Africa, Argentina, Russia, Sweden and Mexico) are compared. Each contributing author was asked to provide similar information, including endophthalmitis rates based on published studies, current practice patterns, and in some cases original survey data. Various methods were used to obtain this information, including literature reviews, expert commentary, and some new survey data not previously published. Results: Many different practice patterns were reported from around the world, specifically with respect to the use of intracameral antibiotics. Conclusion: There is no worldwide consensus regarding endophthalmitis prophylaxis with cataract surgery.

Original languageEnglish (US)
Pages (from-to)565-573
Number of pages9
JournalCurrent Pharmaceutical Design
Volume23
Issue number4
DOIs
StatePublished - Feb 1 2017

Fingerprint

Endophthalmitis
Cataract
Anti-Bacterial Agents
Cefuroxime
Indonesia
Russia
Argentina
South Africa
Mexico
New Zealand
Sweden
Canada
India
China
Japan
Randomized Controlled Trials

Keywords

  • Cataract surgery
  • Cataract surgery complications
  • Endophthalmitis
  • Endophthalmitis prophylaxis
  • Intracameral antibiotics
  • Topical antibiotics

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Endophthalmitis prophylaxis in cataract surgery : Overview of current practice patterns around the world. / Grzybowski, Andrzej; Schwartz, Stephen; Matsuura, Kazuki; Tone, Stephan O.; Arshinoff, Steve; Ng, Jonathon Q.; Meyer, Jay J.; Liu, Wu; Jacob, Soosan; Packer, Mark; Lutfiamida, Rifna; Tahija, Sjakon; Roux, Paul; Malyugin, Boris; Urrets-Zavalia, Julio A.; Crim, Nicolas; Esposito, Evangelina; Daponte, Pablo; Pellegrino, Fernando; Graue-Hernandez, Enrique O.; Jimenez-Corona, Aida; Valdez-Garcia, Jorge E.; Hernandez-Camarena, Julio C.; Relhan, Nidhi; Flynn, Harry W; Ravindran, Ravilla D.; Behnding, Anders.

In: Current Pharmaceutical Design, Vol. 23, No. 4, 01.02.2017, p. 565-573.

Research output: Contribution to journalArticle

Grzybowski, A, Schwartz, S, Matsuura, K, Tone, SO, Arshinoff, S, Ng, JQ, Meyer, JJ, Liu, W, Jacob, S, Packer, M, Lutfiamida, R, Tahija, S, Roux, P, Malyugin, B, Urrets-Zavalia, JA, Crim, N, Esposito, E, Daponte, P, Pellegrino, F, Graue-Hernandez, EO, Jimenez-Corona, A, Valdez-Garcia, JE, Hernandez-Camarena, JC, Relhan, N, Flynn, HW, Ravindran, RD & Behnding, A 2017, 'Endophthalmitis prophylaxis in cataract surgery: Overview of current practice patterns around the world', Current Pharmaceutical Design, vol. 23, no. 4, pp. 565-573. https://doi.org/10.2174/1381612822666161216122230
Grzybowski, Andrzej ; Schwartz, Stephen ; Matsuura, Kazuki ; Tone, Stephan O. ; Arshinoff, Steve ; Ng, Jonathon Q. ; Meyer, Jay J. ; Liu, Wu ; Jacob, Soosan ; Packer, Mark ; Lutfiamida, Rifna ; Tahija, Sjakon ; Roux, Paul ; Malyugin, Boris ; Urrets-Zavalia, Julio A. ; Crim, Nicolas ; Esposito, Evangelina ; Daponte, Pablo ; Pellegrino, Fernando ; Graue-Hernandez, Enrique O. ; Jimenez-Corona, Aida ; Valdez-Garcia, Jorge E. ; Hernandez-Camarena, Julio C. ; Relhan, Nidhi ; Flynn, Harry W ; Ravindran, Ravilla D. ; Behnding, Anders. / Endophthalmitis prophylaxis in cataract surgery : Overview of current practice patterns around the world. In: Current Pharmaceutical Design. 2017 ; Vol. 23, No. 4. pp. 565-573.
@article{e16b96df8ab14671aec18e135cb8423f,
title = "Endophthalmitis prophylaxis in cataract surgery: Overview of current practice patterns around the world",
abstract = "Background: Acute-onset postoperative endophthalmitis after cataract surgery remains a rare but important cause of visual loss. There is no global consensus regarding the optimal strategies for prophylaxis of endophthalmitis and practices vary substantially around the world, especially with respect to the use of intracameral antibiotics. The European Society of Cataract & Refractive Surgeons in a randomized clinical trial (2007) reported an approximately 5-fold reduction in endophthalmitis rates associated with the use of intracameral cefuroxime. Despite this report, the use of intracameral antibiotics has not been universally adopted. Methods: Various endophthalmitis prophylaxis patterns around the world (including the United States, Canada, Australia/New Zealand, Japan, China, India, Indonesia, South Africa, Argentina, Russia, Sweden and Mexico) are compared. Each contributing author was asked to provide similar information, including endophthalmitis rates based on published studies, current practice patterns, and in some cases original survey data. Various methods were used to obtain this information, including literature reviews, expert commentary, and some new survey data not previously published. Results: Many different practice patterns were reported from around the world, specifically with respect to the use of intracameral antibiotics. Conclusion: There is no worldwide consensus regarding endophthalmitis prophylaxis with cataract surgery.",
keywords = "Cataract surgery, Cataract surgery complications, Endophthalmitis, Endophthalmitis prophylaxis, Intracameral antibiotics, Topical antibiotics",
author = "Andrzej Grzybowski and Stephen Schwartz and Kazuki Matsuura and Tone, {Stephan O.} and Steve Arshinoff and Ng, {Jonathon Q.} and Meyer, {Jay J.} and Wu Liu and Soosan Jacob and Mark Packer and Rifna Lutfiamida and Sjakon Tahija and Paul Roux and Boris Malyugin and Urrets-Zavalia, {Julio A.} and Nicolas Crim and Evangelina Esposito and Pablo Daponte and Fernando Pellegrino and Graue-Hernandez, {Enrique O.} and Aida Jimenez-Corona and Valdez-Garcia, {Jorge E.} and Hernandez-Camarena, {Julio C.} and Nidhi Relhan and Flynn, {Harry W} and Ravindran, {Ravilla D.} and Anders Behnding",
year = "2017",
month = "2",
day = "1",
doi = "10.2174/1381612822666161216122230",
language = "English (US)",
volume = "23",
pages = "565--573",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Endophthalmitis prophylaxis in cataract surgery

T2 - Overview of current practice patterns around the world

AU - Grzybowski, Andrzej

AU - Schwartz, Stephen

AU - Matsuura, Kazuki

AU - Tone, Stephan O.

AU - Arshinoff, Steve

AU - Ng, Jonathon Q.

AU - Meyer, Jay J.

AU - Liu, Wu

AU - Jacob, Soosan

AU - Packer, Mark

AU - Lutfiamida, Rifna

AU - Tahija, Sjakon

AU - Roux, Paul

AU - Malyugin, Boris

AU - Urrets-Zavalia, Julio A.

AU - Crim, Nicolas

AU - Esposito, Evangelina

AU - Daponte, Pablo

AU - Pellegrino, Fernando

AU - Graue-Hernandez, Enrique O.

AU - Jimenez-Corona, Aida

AU - Valdez-Garcia, Jorge E.

AU - Hernandez-Camarena, Julio C.

AU - Relhan, Nidhi

AU - Flynn, Harry W

AU - Ravindran, Ravilla D.

AU - Behnding, Anders

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Background: Acute-onset postoperative endophthalmitis after cataract surgery remains a rare but important cause of visual loss. There is no global consensus regarding the optimal strategies for prophylaxis of endophthalmitis and practices vary substantially around the world, especially with respect to the use of intracameral antibiotics. The European Society of Cataract & Refractive Surgeons in a randomized clinical trial (2007) reported an approximately 5-fold reduction in endophthalmitis rates associated with the use of intracameral cefuroxime. Despite this report, the use of intracameral antibiotics has not been universally adopted. Methods: Various endophthalmitis prophylaxis patterns around the world (including the United States, Canada, Australia/New Zealand, Japan, China, India, Indonesia, South Africa, Argentina, Russia, Sweden and Mexico) are compared. Each contributing author was asked to provide similar information, including endophthalmitis rates based on published studies, current practice patterns, and in some cases original survey data. Various methods were used to obtain this information, including literature reviews, expert commentary, and some new survey data not previously published. Results: Many different practice patterns were reported from around the world, specifically with respect to the use of intracameral antibiotics. Conclusion: There is no worldwide consensus regarding endophthalmitis prophylaxis with cataract surgery.

AB - Background: Acute-onset postoperative endophthalmitis after cataract surgery remains a rare but important cause of visual loss. There is no global consensus regarding the optimal strategies for prophylaxis of endophthalmitis and practices vary substantially around the world, especially with respect to the use of intracameral antibiotics. The European Society of Cataract & Refractive Surgeons in a randomized clinical trial (2007) reported an approximately 5-fold reduction in endophthalmitis rates associated with the use of intracameral cefuroxime. Despite this report, the use of intracameral antibiotics has not been universally adopted. Methods: Various endophthalmitis prophylaxis patterns around the world (including the United States, Canada, Australia/New Zealand, Japan, China, India, Indonesia, South Africa, Argentina, Russia, Sweden and Mexico) are compared. Each contributing author was asked to provide similar information, including endophthalmitis rates based on published studies, current practice patterns, and in some cases original survey data. Various methods were used to obtain this information, including literature reviews, expert commentary, and some new survey data not previously published. Results: Many different practice patterns were reported from around the world, specifically with respect to the use of intracameral antibiotics. Conclusion: There is no worldwide consensus regarding endophthalmitis prophylaxis with cataract surgery.

KW - Cataract surgery

KW - Cataract surgery complications

KW - Endophthalmitis

KW - Endophthalmitis prophylaxis

KW - Intracameral antibiotics

KW - Topical antibiotics

UR - http://www.scopus.com/inward/record.url?scp=85018524874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018524874&partnerID=8YFLogxK

U2 - 10.2174/1381612822666161216122230

DO - 10.2174/1381612822666161216122230

M3 - Article

VL - 23

SP - 565

EP - 573

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 4

ER -